Use of p63/P504S Monoclonal Antibody Cocktail in Immunohistochemical Staining of Prostate Tissue

Applied Immunohistochemistry and Molecular Morphology

Volumn 12, Issue 1, 2004, Pages 75-78

  Tacha, David E ^a   Miller, Rodney T ^b  

^a BIOCARE Medical   (United States)

^b ProPath Laboratories Inc   (United States)

Author keywords

Antibody cocktail; Immunohistochemistry; P504S; p63; Prostate

Indexed keywords

CYTOKERATIN; CYTOPLASM PROTEIN; P504S PROTEIN; PROTEIN P63; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN LOCALIZATION; STAINING;

EID: 1542724873     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200403000-00014     Document Type: Article

References (20)

1. Googe PB, McGinley FM, Fitzgibbon JF. Anticytokeratin antibody 34βE12 staining in prostate carcinoma. Am J Clin Pathol. 1997;107:219-223.
2. Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol. 1989;13:389-396.
3. Kahane H, Sharp JW, Shuman GB, et al. Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory. Urology. 1995;45:981-986.
4. Nagle RB, Ahmann FR, McDaniel KM, et al. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res. 1987;47:281-286.
5. Okada H, Tsubura A, Okamura A, et al. Keratin profiles in normal/hyperplastic prostate and prostate carcinoma. Virchows Arch Pathol Anat Histopathol. 1992;421:157-161.
6. O'Malley FP, Grignon DJ, Shum DT. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of prostate gland. Virchows Arch Pathol Anal Histopathol. 1990;417:191-196.
7. Shah IA, Schlageter MO, Stinnett P, et al. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Mod Pathol. 1991;4:220-224.
8. Shin M, Fujita MQ, Stinnett P, et al. Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of prostate. Int J Urol. 1998;5:237-242.
9. Wojno K, Epstein JI. The utility of basal cell-specific anticytokeratin antibody (34βE12) in the diagnosis of prostate cancer. Am J Surg Pathol. 1995;19:251-260.
10. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers 34βE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161-1168.
11. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000;60:1677-1682.
12. Jiang Z, Woda BA, Rock KL, et al. P504S. A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2002;5:1397-1404.
13. Yang XJ, Wu C-L, Woda BA, et al. Expression of α-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921-925.
14. Jiang Z, Wu C-L, Woda BA, et al. P504S/α-methylacyl-CoA racemase. A useful marker for the diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-1174.
15. Beach R, Gown AM, de Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588-1596.
16. Butz WR, Clark KC, Miller RT. Improved manual immunohistochemistry employing orbital mixing of reagents during incubations. Appl Immunohistochem. 1994;2:65-67.
17. Shi S-R, Guo J, Cote RJ, et al. Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry. Appl Immunohistochem Molec Morphol. 1999;7:201-208.
18. Miller RT, Kubier P. Blocking of endogenous avidin-binding activity in immunohistochemistry: The use of egg whites. Appl Immunohistochem. 1997;5:63-66.
19. Kubier P, Miller RT. Tissue protection immunohistochemistry (TPI): A useful adjunct in the interpretation of prostate biopsies and other selected cases where immunostains are needed on minute lesions. Am J Clin Pathol. 2002;117:194-198.
20. Miller RT, Kubier P. Immunohistochemisty on cytologic specimens and previously stained slides (when no paraffin block is available). J Histotechnol. 2002;25:251-257.